Skip to main content
Atrás
Watch Compare

PURPLE BIOTECH LTD.

Calidad de datos: 33%
PPBT
NASDAQ Manufacturing Chemicals
$4.13
▲ $0.19 (4.82%)
Cap. Mercado: 6.06 M
Precio
$3.97
Cap. Mercado
6.06 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

P/E of 0.34 — trading at a low valuation

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Valoración

PE (TTM)
0.34
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1366 pares)
Métrica Acción Mediana del Sector
P/E 0.3 -1.5
P/B — 1.6
ROE % — -53.6
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

1 analista
Buy
Actual
$4.13
+626.4%
Objetivo
$30.00
$30.00
$30.00
$30.00
Pronóstico
P/E Futuro -6.45
EPS Futuro -$0.64
Ingresos Est. 0.0

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$0.64
-$0.64 – -$0.64
 0.0 1
FY2026 -$1.65
-$1.65 – -$1.65
 0.0 1

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$3.40 -$6.16 -81.3%
Q32025 -$2.60 $2.90 +211.5%
Q22025 -$2.10 -$4.00 -90.5%
Q12025 N/A -$1.70 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) 17.83 M
ROE N/A ROA N/A
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) N/A
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value N/A
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 0.34 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap 6.06 M Enterprise Value N/A
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2021
Revenue —
Net Income 17.83 M
EPS (Diluted) —
Gross Profit —
Operating Income —
EBITDA —
R&D Expenses —
SG&A Expenses 6.11 M
D&A —
Interest Expense —
Income Tax —